[go: up one dir, main page]

DE60133581D1 - Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen - Google Patents

Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Info

Publication number
DE60133581D1
DE60133581D1 DE60133581T DE60133581T DE60133581D1 DE 60133581 D1 DE60133581 D1 DE 60133581D1 DE 60133581 T DE60133581 T DE 60133581T DE 60133581 T DE60133581 T DE 60133581T DE 60133581 D1 DE60133581 D1 DE 60133581D1
Authority
DE
Germany
Prior art keywords
lactobacillus casei
stem
compounds derived
probiotic compositions
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133581T
Other languages
English (en)
Other versions
DE60133581T2 (de
Inventor
A Satyanarayan Naidu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROBIO HEALTH
Original Assignee
PROBIO HEALTH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROBIO HEALTH filed Critical PROBIO HEALTH
Application granted granted Critical
Publication of DE60133581D1 publication Critical patent/DE60133581D1/de
Publication of DE60133581T2 publication Critical patent/DE60133581T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE60133581T 2000-12-18 2001-12-17 Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen Expired - Lifetime DE60133581T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25652800P 2000-12-18 2000-12-18
US256528P 2000-12-18
PCT/US2001/048707 WO2002058712A2 (en) 2000-12-18 2001-12-17 Probiotic compounds derived from lactobacillus casei strain ke01

Publications (2)

Publication Number Publication Date
DE60133581D1 true DE60133581D1 (de) 2008-05-21
DE60133581T2 DE60133581T2 (de) 2009-06-04

Family

ID=22972567

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133581T Expired - Lifetime DE60133581T2 (de) 2000-12-18 2001-12-17 Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen

Country Status (13)

Country Link
US (1) US6797266B2 (de)
EP (1) EP1345613B1 (de)
JP (2) JP5186077B2 (de)
KR (1) KR20040018319A (de)
AT (1) ATE391509T1 (de)
AU (1) AU2002246679B2 (de)
BR (1) BR0116349A (de)
CA (1) CA2442602A1 (de)
DE (1) DE60133581T2 (de)
IL (1) IL156490A0 (de)
MX (1) MXPA03005465A (de)
NZ (1) NZ526443A (de)
WO (1) WO2002058712A2 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
US7998470B2 (en) 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
US7026160B2 (en) * 1999-04-30 2006-04-11 Kibow Biotech, Inc. Oral bacteriotherapy compositions and methods
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
JP5186077B2 (ja) * 2000-12-18 2013-04-17 プロバイオヘルス・エルエルシー ラクトバシラス−カゼイｋｅ０１株から得られたプロバイオティック化合物
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US20030175305A1 (en) * 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US7182943B2 (en) * 2002-05-15 2007-02-27 UNIVERSITé LAVAL Method and system for modulation of microbial cell characteristics
GB0212975D0 (en) * 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
AU2003238263A1 (en) * 2002-06-19 2004-01-06 The Board Of Regents Of The University Of Nebraska Lactic acid bacteria cultures that inhibit food-borne pathogens
CA2820023A1 (en) * 2002-09-26 2007-12-19 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
AU2003300208A1 (en) 2003-01-06 2004-08-10 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
ATE504645T1 (de) * 2003-06-23 2011-04-15 Univ North Carolina State Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
WO2005032591A1 (en) * 2003-09-30 2005-04-14 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
CA2609617C (en) 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
PT1962873E (pt) * 2005-12-14 2013-08-29 Oxthera Inc Composições farmacêuticas compreendendo bactérias redutoras de oxalato
CN101405022A (zh) 2005-12-16 2009-04-08 奥克斯赛拉公司 用于减少草酸盐的组合物和方法
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
JP5214464B2 (ja) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
ES2381232T3 (es) * 2007-02-28 2012-05-24 Mead Johnson Nutrition Company Procedimiento para el tratamiento o la prevención de la inflamación sistémica
TW200904340A (en) 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
JP5259253B2 (ja) * 2008-05-19 2013-08-07 森下仁丹株式会社 シームレスカプセル
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
JP2009102324A (ja) * 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
FR2939045B1 (fr) * 2008-12-02 2010-12-31 Daniel Sincholle Compositions pharmaceutiques et nutritionnelles et methode utile pour prevenir et traiter l'inflammation colique et l'endotoxemie metabolique
AU2010218439B2 (en) 2009-02-24 2016-10-20 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2410996B1 (de) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
MY157343A (en) 2009-05-26 2016-05-31 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
BR112012018839B1 (pt) 2010-01-28 2020-04-14 Advanced Bionutrition Corp composição vítrea seca compreendendo um material bioativo
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US7888062B1 (en) 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US8445226B2 (en) 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
IT1405395B1 (it) * 2010-08-05 2014-01-10 Proge Farm Srl Composizioni di probiotici e oli e loro uso.
PL2603100T3 (pl) 2010-08-13 2019-06-28 Advanced Bionutrition Corp. Kompozycja stabilizująca przechowywanie na sucho materiałów biologicznych
WO2012044984A1 (en) 2010-09-30 2012-04-05 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
CL2010001628A1 (es) 2010-12-30 2011-04-25 Univerisidad De Concepcion Alimento probiotico para peces que comprende lactobacillus plantarum, lactococcus lactis lactis, pediococcus acidilactic, pediococcus damnosus y/o plantarum, harina y descartes de pescado, poroto de soya, harina de trigo, aceite de pescado y almidon de maiz; y proceso de elaboracion de dicho alimento.
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
CN106535909A (zh) 2014-07-01 2017-03-22 普罗比美国公司 双层双重释放益生菌片剂
CA2957790A1 (en) * 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof
EP3217992A4 (de) * 2014-11-10 2018-07-18 National Institutes Of Health Probiotische therapeutische anwendungen
ES2862176T3 (es) 2014-12-12 2021-10-07 Univ California Reducción de los glucanos de la leche y sus productos de degradación en el intestino del recién nacido
MY194231A (en) 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
WO2017027742A1 (en) 2015-08-11 2017-02-16 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
EP4349355A1 (de) 2016-06-13 2024-04-10 Murata Manufacturing Co., Ltd. Antimikrobielles und antivirales mittel, antimikrobielles und antivirales element und verfahren zur herstellung eines antimikrobiellen und antiviralen mittels
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
RU2674772C1 (ru) * 2017-11-09 2018-12-13 Тарас Владимирович Герунов Способ профилактики отравлений у животных
CN110643533B (zh) * 2019-09-24 2020-11-13 扬州大学 降解油脂的干酪乳杆菌及其应用
BR112022018377A2 (pt) 2020-03-16 2022-11-08 Biosearch S A Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos
CN111560330B (zh) * 2020-05-12 2022-04-26 天津科技大学 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
WO2022082027A1 (en) * 2020-10-15 2022-04-21 University Of Louisville Research Foundation, Inc. Probiotic delivery systems and methods of making and using
MX2023007685A (es) * 2020-12-25 2023-11-22 Hayashibara Co Método para mejorar la productividad en ganado y aves de corral y método para mejorar la flora intestinal en ganado y/o aves de corral.
CN112625979B (zh) * 2021-01-14 2023-01-06 四川大学华西医院 一种对抗幽门螺杆菌的干酪乳杆菌及其应用
WO2025043142A1 (en) * 2023-08-23 2025-02-27 The United States Government As Represented By The Department Of Veterans Affairs Compositions comprising lactobacillus strains, and methods of treating osteoarthritis and osteoarthritis co-morbidities

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2421066A1 (de) 1974-05-02 1976-03-25 Solco Basel Ag Bifidobakterien enthaltendes praeparat
US3957974A (en) 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS52102419A (en) 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
US4210672A (en) 1976-04-02 1980-07-01 Seikenkai Preparation of yogurt
JPS587297B2 (ja) 1976-05-21 1983-02-09 秦 興世 脱臭剤とその製造方法及び保存法
JPS52154590A (en) 1976-05-21 1977-12-22 Seikenkai Cultivating and preserving method of deodorising lactobucillus and liling cell preparation
JPS5911177A (ja) 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
JPS60149527A (ja) 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5804179A (en) 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
AU624067B2 (en) 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JP2506314B2 (ja) * 1993-10-27 1996-06-12 全国農業協同組合連合会 家禽・豚の敗血症の予防・治療剤及び飼料
NZ287420A (en) 1994-05-26 1997-12-19 Bracco Spa Lactobacillus strains with enhanced gut adhesion
AUPM823094A0 (en) 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
US6274564B1 (en) 1996-09-18 2001-08-14 William J. Sarill Compositions of cobalamin and related corrinoids, and uses thereof
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
US5965128A (en) 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
ES2258841T3 (es) * 1998-04-01 2006-09-01 Ganeden Biotech, Inc. Procedimientos para reducir el colesterol con esporas de bacillus coagulans, sistemas y composiciones asociados.
DE69924141D1 (de) * 1998-12-11 2005-04-14 Urex Biotech Inc Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
JP2000197469A (ja) * 1999-01-08 2000-07-18 New Food Creation Gijutsu Kenkyu Kumiai 血清脂質改善効果を有する機能性飲食品
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
JP5186077B2 (ja) * 2000-12-18 2013-04-17 プロバイオヘルス・エルエルシー ラクトバシラス−カゼイｋｅ０１株から得られたプロバイオティック化合物

Also Published As

Publication number Publication date
AU2002246679B2 (en) 2006-11-16
EP1345613A2 (de) 2003-09-24
JP2004525106A (ja) 2004-08-19
DE60133581T2 (de) 2009-06-04
CA2442602A1 (en) 2002-08-01
KR20040018319A (ko) 2004-03-03
US6797266B2 (en) 2004-09-28
ATE391509T1 (de) 2008-04-15
NZ526443A (en) 2005-03-24
MXPA03005465A (es) 2004-10-14
WO2002058712A3 (en) 2003-06-05
EP1345613B1 (de) 2008-04-09
WO2002058712A2 (en) 2002-08-01
JP2010195778A (ja) 2010-09-09
JP5186077B2 (ja) 2013-04-17
BR0116349A (pt) 2003-12-23
US20020192202A1 (en) 2002-12-19
IL156490A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
DE60133581D1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
CY1107671T1 (el) Νεα συνθεση γαλακτοολιγοσακχαριτη και η παρασκευη της
DE60205646D1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
MXPA04008182A (es) Composicion fotoprotectora para la piel, oralmente adminstrable.
WO2005060707A3 (en) Methods of use of probiotic lactobacilli for companion animals
BRPI0418986A (pt) cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
DE60139554D1 (de) Probiotika zur primären prävention atopischer erkrankungen
DK1699474T4 (da) Probiotiske tabletformuleringer
NO20070699L (no) Spesielle aminoalkylglukosaminidfosfatforbindelser og deres anvendelse
EA200201248A1 (ru) Применение lactobacillus casei в иммуностимуляторных пептидах
ATE413888T1 (de) Salmonella vakzine
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
EA200702254A1 (ru) Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант
DE69927930D1 (de) Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora
DE60330549D1 (de) Zur desinfektion von helicobacter pylori befähigter käse
ATE421990T1 (de) Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
AU2003206926A8 (en) Cultivation method for micro-organisms and bioreactor
WO2008002484A3 (en) Novel lactobacillus bulgaricus strain and compositions
RU2001135343A (ru) Штамм бактерий Bifidobacterium longum 58B для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
EA200701730A1 (ru) Бактериоцины и новые бактериальные штаммы
RU2002103078A (ru) Способ профилактики диарейных болезней новорожденных телят и поросят

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: STROHSCHAENK UND KOLLEGEN, 85521 OTTOBRUNN